Primary anti-phospholipid antibody syndrome: real-world defining features of rethrombosis in the course of disease

HIGHLIGHTS

• who: Melissa Fernandes and colleagues from the Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden have published the paper: Primary Anti-Phospholipid Antibody Syndrome: Real-World Defining Features of Rethrombosis in the Course of Disease, in the Journal: International Journal of Rheumatology of 10/Nov/2022
• what: The authors aimed to identify features that allow differentiation of primary antiphospholipid syndrome (PAPS) patients that suffer recurrent thrombotic events (RTE) despite anticoagulation from the other diagnosed PAPS patients.
• how: Owing to the exploratory nature of this study differences were considered statistically significant for a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.